261 related articles for article (PubMed ID: 11363049)
1. Lamivudine (3TC) approved for combination use with AZT.
James JS
AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
[TBL] [Abstract][Full Text] [Related]
2. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
3. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
5. 3TC approved: now for the tough questions.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):6-8. PubMed ID: 11363101
[TBL] [Abstract][Full Text] [Related]
6. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
7. AZT studies reinforce benefits of combination.
AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
[TBL] [Abstract][Full Text] [Related]
8. Combination antiretroviral treatment: new views, evolving practices.
James JS
AIDS Treat News; 1995 Jul; (no 226):1-2. PubMed ID: 11362612
[TBL] [Abstract][Full Text] [Related]
9. 3TC and saquinavir: we need them now.
Baker R
BETA; 1995 Sep; ():3. PubMed ID: 11362889
[TBL] [Abstract][Full Text] [Related]
10. 3TC: now available again up to CD4 of 300.
AIDS Treat News; 1995 Aug; (no 228):4. PubMed ID: 11362624
[TBL] [Abstract][Full Text] [Related]
11. A closer look at 3TC. Interview by Mark Mascolini.
Rubin M
J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724
[TBL] [Abstract][Full Text] [Related]
12. 3TC: Glaxo Wellcome broadens patient assistance.
AIDS Treat News; 1996 Jun; (no 248):6-7. PubMed ID: 11363595
[TBL] [Abstract][Full Text] [Related]
13. AZT and 3TC.
Treat Rev; 1996 Apr; (no 21):4. PubMed ID: 11363395
[TBL] [Abstract][Full Text] [Related]
14. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
James JS
AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
[TBL] [Abstract][Full Text] [Related]
15. 3TC and AZT.
Treat Rev; 1995; (no 17):2. PubMed ID: 11362294
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral drug resistance.
Japour AJ
AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787
[TBL] [Abstract][Full Text] [Related]
17. What we know about anti-HIV drugs.
Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
[TBL] [Abstract][Full Text] [Related]
18. FDA triple header. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
[TBL] [Abstract][Full Text] [Related]
19. Combination 3TC/AZT therapy shows promise.
AIDS Clin Care; 1995 Mar; 7(3):22. PubMed ID: 11362192
[TBL] [Abstract][Full Text] [Related]
20. New drugs for HIV infection.
Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
